Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

By type of insulin, the long-acting insulin analogs segment accounted for the highest revenue-grossing segment in the global ...

The government is also exploring alternative medications to improve treatment options and ensure a steady supply for diabetic ...

Compared with subcutaneous insulin analogs, inhaled insulin has a similar rate of onset and time to peak action, but a longer duration of action. With inhaled insulin, needles are replaced by a ...

Objectives: The prevalence, causes, and consequences of nocturnal hypoglycemia as well as detection and prevention strategies are reviewed, including the use of long-acting insulin analogs ...

However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...

Can long-acting insulin analogs help overcome the challenge of nocturnal hypoglycemia? On the basis of this review of clinical trial results, insulin detemir or insulin glargine may be the best ...

These days, many diabetes patients in wealthier nations rely on analog insulin to control their blood sugar. Compared to human insulin, analog insulin tends to work faster and can be modified to ...